IL319790A - Terpostinil in dry powder form for the treatment of pulmonary hypertension - Google Patents
Terpostinil in dry powder form for the treatment of pulmonary hypertensionInfo
- Publication number
- IL319790A IL319790A IL319790A IL31979025A IL319790A IL 319790 A IL319790 A IL 319790A IL 319790 A IL319790 A IL 319790A IL 31979025 A IL31979025 A IL 31979025A IL 319790 A IL319790 A IL 319790A
- Authority
- IL
- Israel
- Prior art keywords
- treprostinil
- dose
- micrograms
- dry powder
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662332013P | 2016-05-05 | 2016-05-05 | |
| US201662404960P | 2016-10-06 | 2016-10-06 | |
| US201662440078P | 2016-12-29 | 2016-12-29 | |
| US201762472204P | 2017-03-16 | 2017-03-16 | |
| PCT/US2017/031301 WO2017192993A1 (en) | 2016-05-05 | 2017-05-05 | Dry powder treprostinil for the treatment of pulmonary hypertension |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL319790A true IL319790A (en) | 2025-05-01 |
Family
ID=60203775
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL319790A IL319790A (en) | 2016-05-05 | 2017-05-05 | Terpostinil in dry powder form for the treatment of pulmonary hypertension |
| IL262720A IL262720B2 (en) | 2016-05-05 | 2017-05-05 | Dry powder treprostinil for the treatment of pulmonary hypertension |
| IL310250A IL310250B2 (en) | 2016-05-05 | 2017-05-05 | Terpostinil in dry powder form for the treatment of pulmonary hypertension |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL262720A IL262720B2 (en) | 2016-05-05 | 2017-05-05 | Dry powder treprostinil for the treatment of pulmonary hypertension |
| IL310250A IL310250B2 (en) | 2016-05-05 | 2017-05-05 | Terpostinil in dry powder form for the treatment of pulmonary hypertension |
Country Status (7)
| Country | Link |
|---|---|
| US (9) | US10898494B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3452170A4 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2019519489A (cg-RX-API-DMAC7.html) |
| AU (3) | AU2017261317A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3023257A1 (cg-RX-API-DMAC7.html) |
| IL (3) | IL319790A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017192993A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010259943C1 (en) | 2009-06-12 | 2016-03-03 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
| EP2861296A1 (en) * | 2012-06-15 | 2015-04-22 | Case Western Reserve University | Therapy delivery devices and methods for non-damaging neural tissue conduction block |
| BR112015023168B1 (pt) | 2013-03-15 | 2021-08-10 | Mannkind Corporation | Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina |
| BR122019026637B1 (pt) | 2013-07-18 | 2023-09-26 | Mannkind Corporation | Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco |
| US9469600B2 (en) | 2013-10-25 | 2016-10-18 | Insmed Incorporated | Prostacyclin compounds, compositions and methods of use thereof |
| US10343979B2 (en) | 2014-11-18 | 2019-07-09 | Insmed Incorporated | Methods of manufacturing treprostinil and treprostinil derivative prodrugs |
| US20190321290A1 (en) * | 2016-01-29 | 2019-10-24 | Mannkind Corporation | Composition and method for inhalation |
| EP3452170A4 (en) | 2016-05-05 | 2020-04-01 | Liquidia Technologies, Inc. | TREPROSTINIL IN POWDER FORM FOR TREATING PULMONAL HYPERTENSION |
| SG11202011045VA (en) * | 2018-05-07 | 2020-12-30 | Pharmosa Biopharm Inc | Pharmaceutical composition for controlled release of treprostinil |
| CA3102967A1 (en) * | 2018-06-07 | 2019-12-12 | Mannkind Corporation | Composition and method for inhalation |
| CN119632930A (zh) | 2019-04-29 | 2025-03-18 | 英斯梅德股份有限公司 | 曲前列素前药的干粉组合物及其使用方法 |
| CN114401716A (zh) | 2019-07-22 | 2022-04-26 | 纳诺米有限公司 | 持续释放的曲前列环素-化合物微粒组合物 |
| IL296567A (en) | 2020-04-17 | 2022-11-01 | United Therapeutics Corp | Terfostinil for use in the treatment of interstitial lung disease |
| CN116437906B (zh) * | 2020-10-28 | 2026-07-03 | 英斯梅德股份有限公司 | 曲前列环素前药的干粉组合物和其使用方法 |
| CA3235985A1 (en) * | 2021-10-27 | 2023-05-04 | Mannkind Corporation | Methods and compositions for treating pulmonary hypertension |
| WO2023154705A1 (en) * | 2022-02-08 | 2023-08-17 | United Therapeutics Corporation | Treprostinil iloprost combination therapy |
| EP4516297A4 (en) | 2022-04-29 | 2026-02-25 | Zhaoke pharmaceutical guangzhou co ltd | Treprostinil Gentle Inhalation Mist |
| WO2025174856A1 (en) * | 2024-02-12 | 2025-08-21 | Mannkind Corporation | Process for making a composition for pulmonary inhalation |
Family Cites Families (84)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56122328A (en) | 1980-02-29 | 1981-09-25 | Sumitomo Chem Co Ltd | Crystalline amine salt of methanoplastocyclin, its preparation and purifying method |
| US4306075A (en) | 1980-03-28 | 1981-12-15 | The Upjohn Company | Composition and process |
| GB8814438D0 (en) | 1988-06-17 | 1988-07-20 | Wellcome Found | Compounds for use in medicine |
| US5441060A (en) * | 1993-02-08 | 1995-08-15 | Duke University | Dry powder delivery system |
| CH687615A5 (de) * | 1994-09-07 | 1997-01-15 | R W Johnson Pharmaceutical Res | Tropen-Verpackung. |
| US6503480B1 (en) | 1997-05-23 | 2003-01-07 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| US6441245B1 (en) | 1997-10-24 | 2002-08-27 | United Therapeutics Corporation | Process for stereoselective synthesis of prostacyclin derivatives |
| US20030118567A1 (en) | 1999-03-26 | 2003-06-26 | Stewart Duncan John | Cell-based therapy for the pulmonary system |
| US6521212B1 (en) * | 1999-03-18 | 2003-02-18 | United Therapeutics Corporation | Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation |
| US6858199B1 (en) | 2000-06-09 | 2005-02-22 | Advanced Inhalation Research, Inc. | High efficient delivery of a large therapeutic mass aerosol |
| US7305986B1 (en) * | 1999-07-23 | 2007-12-11 | Mannkind Corporation | Unit dose capsules for use in a dry powder inhaler |
| US6242482B1 (en) | 2000-06-05 | 2001-06-05 | United Therapeutics Corporation | Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failure |
| EG24184A (en) * | 2001-06-15 | 2008-10-08 | Otsuka Pharma Co Ltd | Dry powder inhalation system for transpulmonary |
| US6889690B2 (en) * | 2002-05-10 | 2005-05-10 | Oriel Therapeutics, Inc. | Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages |
| GB0219511D0 (en) * | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Method of preparing dry powder inhalation compositions |
| CN102697790A (zh) | 2003-05-22 | 2012-10-03 | 联合治疗公司 | 化合物和释放前列环素类似物的方法 |
| AU2004249166B2 (en) | 2003-06-13 | 2008-10-09 | Alkermes, Inc. | Low dose pharmaceutical powders for inhalation |
| US20040265238A1 (en) | 2003-06-27 | 2004-12-30 | Imtiaz Chaudry | Inhalable formulations for treating pulmonary hypertension and methods of using same |
| ATE551383T1 (de) | 2003-09-23 | 2012-04-15 | Univ North Carolina | Photohärtbare perfluorpolyether zur verwendung als neue werkstoffe in mikrofluidischen vorrichtungen |
| US7199157B2 (en) | 2003-12-16 | 2007-04-03 | United Therapeutics Corporation | Use of treprostinil to improve kidney functions |
| CN1917866B (zh) | 2003-12-16 | 2010-12-15 | 联合治疗公司 | 曲前列环素或它的衍生物,或其药学上可接受的盐在制备治疗和预防缺血性损害的药物中的用途 |
| WO2005101466A2 (en) | 2003-12-19 | 2005-10-27 | The University Of North Carolina At Chapel Hill | Methods for fabricating isolated micro- and nano- structures using soft or imprint lithography |
| US9214590B2 (en) | 2003-12-19 | 2015-12-15 | The University Of North Carolina At Chapel Hill | High fidelity nano-structures and arrays for photovoltaics and methods of making the same |
| WO2007021762A2 (en) | 2005-08-09 | 2007-02-22 | The University Of North Carolina At Chapel Hill | Methods and materials for fabricating microfluidic devices |
| DE602005020269D1 (de) | 2004-04-12 | 2010-05-12 | United Therapeutics Corp | Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren |
| CA2574958A1 (en) | 2004-07-26 | 2006-02-09 | Cotherix, Inc. | Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation |
| HUE025151T2 (en) | 2004-08-23 | 2016-01-28 | Mannkind Corp | Diceto-piperazine salts for drug delivery |
| WO2007133808A2 (en) | 2006-05-15 | 2007-11-22 | Liquidia Technologies, Inc. | Nano-particles for cosmetic applications |
| CA2654492C (en) | 2006-05-15 | 2017-06-27 | United Therapeutics Corporation | Treprostinil administration using a metered dose inhaler |
| CA2655477C (en) | 2006-06-16 | 2015-05-05 | Cipla Limited | Vibration assisted release of encapsulated inhalable powder |
| US20090036465A1 (en) | 2006-10-18 | 2009-02-05 | United Therapeutics Corporation | Combination therapy for pulmonary arterial hypertension |
| US8128393B2 (en) | 2006-12-04 | 2012-03-06 | Liquidia Technologies, Inc. | Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom |
| WO2009049299A1 (en) | 2007-10-12 | 2009-04-16 | Liquidia Technologies, Inc. | System and method for producing particles and patterned films |
| WO2009078965A1 (en) | 2007-12-17 | 2009-06-25 | United Therapeutics Corporation | An improved process to prepare treprostinil, the active ingredient in remodulin |
| US20110151015A1 (en) | 2008-03-04 | 2011-06-23 | Liquikia Technologies, Inc. | Immunomodulator particles and methods of treating |
| EP2257326A2 (en) * | 2008-03-21 | 2010-12-08 | Novartis AG | Powder dispersion apparatus |
| JP6219016B2 (ja) | 2008-05-08 | 2017-10-25 | ユナイテッド セラピューティクス コーポレーション | トレプロスチニル一水和物 |
| WO2009150136A1 (de) | 2008-06-09 | 2009-12-17 | Boehringer Ingelheim International Gmbh | Neue einbettungspartikel für die inhalation |
| WO2009152160A1 (en) * | 2008-06-10 | 2009-12-17 | Gilead Sciences, Inc. | Inhaled carbaprostacyclin and prostacyclin prodrugs for the treatment of pulmonary arterial hypertension |
| EP2330893A4 (en) | 2008-09-25 | 2013-01-09 | Aradigm Corp | DEEP PULMONARY ADMINISTRATION OF TREPROSTINIL |
| CN104162947B (zh) | 2008-12-05 | 2017-04-12 | 流体科技公司 | 产生有图案的材料的方法 |
| AU2010259943C1 (en) | 2009-06-12 | 2016-03-03 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
| US20120114554A1 (en) | 2009-07-13 | 2012-05-10 | Liquidia Technologies, Inc. | Engineered Aerosol Particles, And Associated Methods |
| AU2010280684B2 (en) | 2009-08-07 | 2016-07-28 | Scipharm Sarl | Composition for the treatment of cystic fibrosis |
| EP2338520A1 (de) | 2009-12-21 | 2011-06-29 | Ludwig Maximilians Universität | Konjugat mit Zielfindungsligand und dessen Verwendung |
| US20130209564A1 (en) | 2010-02-22 | 2013-08-15 | Shyam M. Rele | Polysaccharide Particle Vaccines |
| CN102869402A (zh) * | 2010-04-23 | 2013-01-09 | 3M创新有限公司 | 干粉吸入器组件和容器 |
| CA2726599C (en) | 2010-12-30 | 2017-07-25 | Alphora Research Inc. | Process for treprostinil salt preparation |
| PL2663313T3 (pl) | 2011-01-13 | 2019-01-31 | SciPharm S.à r.l. | Sposób zwiększania wszczepiania hematopoetycznych komórek macierzystych |
| JP5780775B2 (ja) | 2011-02-18 | 2015-09-16 | 株式会社Lttバイオファーマ | プロスタグランジンi2誘導体を含有するナノ粒子 |
| EP2526926A1 (de) | 2011-05-25 | 2012-11-28 | Justus-Liebig-Universität Gießen | Biokompatible Nanopolymerpartikel mit Wirkstoffen für die pulmonale Applikation |
| AU2012296953B2 (en) | 2011-08-12 | 2016-10-20 | Ascendis Pharma A/S | Sustained release composition of prostacyclin |
| CA2850484C (en) | 2011-09-30 | 2021-01-26 | Bluebird Bio, Inc. | Compounds for improved viral transduction |
| AU2012328524B2 (en) * | 2011-10-28 | 2017-05-18 | Excelse Bio, Inc. | Protein formulations containing amino acids |
| US9554968B2 (en) | 2013-03-11 | 2017-01-31 | Sio2 Medical Products, Inc. | Trilayer coated pharmaceutical packaging |
| CN107875127A (zh) | 2012-02-28 | 2018-04-06 | 艾塞尤提卡控股公司 | 可吸入药物组合物 |
| US20150136130A1 (en) * | 2012-02-29 | 2015-05-21 | Pulmatrix, Inc. | Inhalable dry powders |
| US10071209B2 (en) | 2012-03-15 | 2018-09-11 | Steadymed Ltd. | Enhanced infusion-site pain-reduction for drug-delivery devices |
| CN104684561A (zh) | 2012-08-01 | 2015-06-03 | 联合治疗公司 | 利用间充质干细胞的肺动脉高血压的治疗 |
| WO2014085813A1 (en) | 2012-11-30 | 2014-06-05 | Insmed Incorporated | Prostacylin compositions and methods for using the same |
| US9505737B2 (en) * | 2013-01-11 | 2016-11-29 | Corsair Pharma, Inc. | Treprostinil derivative compounds and methods of using same |
| WO2014159050A1 (en) | 2013-03-14 | 2014-10-02 | United Therapeutics Corporation | Solid forms of treprostinil |
| BR112015023168B1 (pt) | 2013-03-15 | 2021-08-10 | Mannkind Corporation | Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina |
| ITMI20130572A1 (it) * | 2013-04-10 | 2014-10-11 | Eratech Srl | Composizione comprendente almeno due polveri secche ottenute per spray dry per aumentare la stabilita' della formulazione |
| CA2911172C (en) | 2013-04-30 | 2021-10-19 | United Therapeutics Corporation | Controlled release pharmaceutical formulations |
| US9349730B2 (en) | 2013-07-18 | 2016-05-24 | Globalfoundries Inc. | Fin transformation process and isolation structures facilitating different Fin isolation schemes |
| BR122019026637B1 (pt) * | 2013-07-18 | 2023-09-26 | Mannkind Corporation | Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco |
| ES2959419T3 (es) * | 2013-10-11 | 2024-02-26 | Pulmokine Inc | Formulaciones secas por aspersión |
| US9469600B2 (en) | 2013-10-25 | 2016-10-18 | Insmed Incorporated | Prostacyclin compounds, compositions and methods of use thereof |
| GB201400412D0 (en) * | 2014-01-10 | 2014-02-26 | Heart Biotech Ltd | Pharmaceutical formulations for the treatment of pulmonary arterial hypertension |
| MX2016010213A (es) | 2014-02-07 | 2017-04-13 | Auspex Pharmaceuticals Inc | Formulaciones farmaceuticas novedosas. |
| WO2015138423A1 (en) * | 2014-03-11 | 2015-09-17 | Insmed Incorporated | Prostacylin compositions and methods for using the same |
| CA2963085C (en) * | 2014-10-07 | 2023-02-21 | Lam Therapeutics, Inc. | An inhalable rapamycin formulation for the treatment of pulmonary hypertension |
| US9643911B2 (en) | 2015-06-17 | 2017-05-09 | Corsair Pharma, Inc. | Treprostinil derivatives and compositions and uses thereof |
| US9394227B1 (en) | 2015-06-17 | 2016-07-19 | Corsair Pharma, Inc. | Treprostinil derivatives and compositions and uses thereof |
| IL260823B2 (en) | 2016-01-29 | 2024-08-01 | Mannkind Corp | Dry powder inhaler |
| US20190321290A1 (en) | 2016-01-29 | 2019-10-24 | Mannkind Corporation | Composition and method for inhalation |
| EP3452170A4 (en) | 2016-05-05 | 2020-04-01 | Liquidia Technologies, Inc. | TREPROSTINIL IN POWDER FORM FOR TREATING PULMONAL HYPERTENSION |
| EP3554507A1 (en) | 2016-12-14 | 2019-10-23 | Respira Therapeutics, Inc. | Methods and compositions for treatment of pulmonary hypertension and other lung disorders |
| CA3102967A1 (en) | 2018-06-07 | 2019-12-12 | Mannkind Corporation | Composition and method for inhalation |
| CN112739679B (zh) | 2018-09-18 | 2024-03-12 | 伊莱利利公司 | 曲前列环素的特丁胺盐 |
| JP7365073B2 (ja) | 2019-05-21 | 2023-10-19 | ジァンスー フォアフロント ファーマシューティカル カンパニー,リミテッド | トレプロスチニルナトリウムの新規な結晶形および製造方法 |
| CN114401716A (zh) | 2019-07-22 | 2022-04-26 | 纳诺米有限公司 | 持续释放的曲前列环素-化合物微粒组合物 |
-
2017
- 2017-05-05 EP EP17793448.6A patent/EP3452170A4/en active Pending
- 2017-05-05 IL IL319790A patent/IL319790A/en unknown
- 2017-05-05 CA CA3023257A patent/CA3023257A1/en active Pending
- 2017-05-05 IL IL262720A patent/IL262720B2/en unknown
- 2017-05-05 JP JP2018558275A patent/JP2019519489A/ja active Pending
- 2017-05-05 WO PCT/US2017/031301 patent/WO2017192993A1/en not_active Ceased
- 2017-05-05 US US16/099,135 patent/US10898494B2/en active Active
- 2017-05-05 IL IL310250A patent/IL310250B2/en unknown
- 2017-05-05 AU AU2017261317A patent/AU2017261317A1/en not_active Abandoned
-
2020
- 2020-11-25 US US17/104,348 patent/US11712442B2/en active Active
-
2021
- 2021-07-30 US US17/390,514 patent/US11744836B2/en active Active
- 2021-07-30 US US17/390,476 patent/US11744835B2/en active Active
-
2022
- 2022-04-13 US US17/719,439 patent/US11660304B2/en active Active
-
2023
- 2023-03-01 JP JP2023031081A patent/JP2023071844A/ja active Pending
- 2023-03-02 AU AU2023201307A patent/AU2023201307A1/en not_active Abandoned
- 2023-07-12 US US18/350,926 patent/US12390475B2/en active Active
-
2025
- 2025-05-07 JP JP2025077118A patent/JP2025118785A/ja active Pending
- 2025-06-10 AU AU2025204321A patent/AU2025204321A1/en active Pending
- 2025-07-07 US US19/261,256 patent/US20250332175A1/en active Pending
-
2026
- 2026-03-26 US US19/629,817 patent/US20260216209A1/en active Pending
- 2026-03-26 US US19/629,870 patent/US20260216210A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2025204321A1 (en) | 2025-06-26 |
| IL262720A (en) | 2018-12-31 |
| IL262720B1 (en) | 2024-02-01 |
| US20220257608A1 (en) | 2022-08-18 |
| IL310250B2 (en) | 2025-09-01 |
| EP3452170A1 (en) | 2019-03-13 |
| AU2017261317A1 (en) | 2018-12-13 |
| US11712442B2 (en) | 2023-08-01 |
| EP3452170A4 (en) | 2020-04-01 |
| US11744835B2 (en) | 2023-09-05 |
| US20260216209A1 (en) | 2026-07-30 |
| IL310250A (en) | 2024-03-01 |
| US11744836B2 (en) | 2023-09-05 |
| US20190151332A1 (en) | 2019-05-23 |
| JP2019519489A (ja) | 2019-07-11 |
| US20260216210A1 (en) | 2026-07-30 |
| WO2017192993A1 (en) | 2017-11-09 |
| US11660304B2 (en) | 2023-05-30 |
| US20230346799A1 (en) | 2023-11-02 |
| JP2025118785A (ja) | 2025-08-13 |
| CA3023257A1 (en) | 2017-11-09 |
| IL310250B1 (en) | 2025-05-01 |
| US20210077504A1 (en) | 2021-03-18 |
| US20250332175A1 (en) | 2025-10-30 |
| IL262720B2 (en) | 2024-06-01 |
| US20210353640A1 (en) | 2021-11-18 |
| US20210353641A1 (en) | 2021-11-18 |
| AU2023201307A1 (en) | 2023-04-06 |
| US12390475B2 (en) | 2025-08-19 |
| US10898494B2 (en) | 2021-01-26 |
| JP2023071844A (ja) | 2023-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12390475B2 (en) | Dry powder treprostinil for the treatment of pulmonary hypertension | |
| RU2275900C2 (ru) | Способ высокоэффективной доставки аэрозоля с большой терапевтической массой | |
| RU2580312C2 (ru) | Способ получения частиц с пониженным электростатическим зарядом | |
| TWI539979B (zh) | 用於經由肺部遞送長效蕈毒鹼拮抗劑及長效β腎上腺素受體激動劑之組成物,及相關方法及系統 | |
| JP2021522163A (ja) | 肺疾患の処置に使用するための吸入可能なリポソーム徐放性組成物 | |
| US11160754B2 (en) | Methods for treating lung disorders | |
| US20240122889A1 (en) | Dry powder compositions of treprostinil prodrugs and methods of use thereof | |
| IL312346A (en) | Preparations for the treatment of pulmonary hypertension | |
| IL302994A (en) | Inhaled imatinib for field pulmonary hypertension | |
| CA3268243A1 (en) | CAPSULE INHALATOR FOR THE ADMINISTRATION OF A PHOSPHODIESTERASE-4 INHIBITOR | |
| JP2023552600A (ja) | 結晶状態のポリコナゾールを含む吸入粉末剤 | |
| AU2015201037B2 (en) | Respiratory delivery of active agents | |
| TW202612690A (zh) | 用於治療肺疾病之方法及化合物 | |
| WO2026064480A1 (en) | Method and composition for treating lung diseases | |
| CN107205958A (zh) | 包含福莫特罗和布地奈德的药物组合物 | |
| IL323261A (en) | Spray-dried treprostinil formulation | |
| AU2016202397B2 (en) | Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations | |
| HK40043569A (en) | Inhalable liposomal sustained release composition for use in treating pulmonary diseases | |
| Hassanpour Aghdam | Dry powder inhalation of Itraconazole-loaded nanotransferosome: formulation and aerodynamic characteristics |